SKYCLARYS® Approved by FDA in the U.S.
Approximately 500 Patient Start Forms Received for SKYCLARYS
Marketing Authorization Application for Omaveloxolone in Europe Under Review
Announced. | May 10, 2023
Aytu BioPharma Announces Approval of Adzenys XR-ODT(R)Manufacturing Site Transfer phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.
Alembic Pharmaceuticals Ltd has received PAS approval from the US Food & Drug Administration for its sANDA Pregabalin Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg.
Revance Therapeutics, Inc. (NASDAQ:NASDAQ:RVNC) Q3 2022 Results Conference Call November 08, 2022 04:30 PM ET Company Participants Jessica Serra - Head of Investor Relations & ESG Mark.